Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial. (Q39668099)

From Wikidata
Jump to: navigation, search
scientific article published on 20 June 2016
edit
Language Label Description Also known as
English
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.
scientific article published on 20 June 2016

    Statements

    Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial. (English)
    1 reference
    Nick Pavlakis
    1 reference
    Andrew J Martin
    1 reference
    Eric Tsobanis
    1 reference
    Sonia Yip
    1 reference
    Yoon-Koo Kang
    1 reference
    Yung-Jue Bang
    1 reference
    Thierry Alcindor
    1 reference
    Christopher J O'Callaghan
    1 reference
    Margot J Burnell
    1 reference
    Niall C Tebbutt
    1 reference
    Sun Young Rha
    1 reference
    Jeeyun Lee
    1 reference
    Jae-Yong Cho
    1 reference
    Lara R Lipton
    1 reference
    Mark Wong
    1 reference
    Andrew Strickland
    1 reference
    Jin Won Kim
    1 reference
    John R Zalcberg
    1 reference
    John Simes
    1 reference
    David Goldstein
    1 reference
    20 June 2016
    1 reference
    34
    1 reference
    2728-2735
    1 reference
    23
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit